A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec

Clinical trial NCT07332000 · RECRUITING

Trial details

NCT number: NCT07332000
Sponsor: Candel Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Patients Treated by Radiotherapy Prostate Cancer (Adenocarcinoma)

Start date: 2025-10-30
Primary completion: 2026-08-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.